Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep' 25	Jun' 25	Mar' 25	Dec' 24	Sep' 24

Sales

522.15

498.62

555.96

550.92

609.96

Operating profit

62.22

67.23

67.93

74.10

63.03

Interest

29.41

30.45

29.36

34.21

50.15

Gross profit

46.90

38.54

50.69

42.31

36.43

EPS (Rs)

3.48

1.45

1.75

1.62

1.66

Other income

14.09

1.76

12.12

2.43

23.55

Stock adjustment

-3.65

15.46

3.30

-47.96

6.14

Raw material

255.66

210.98

268.29

295.26

301.91

Power and fuel

-

-

-

-

-

Employee expenses

96.49

94.04

91.86

93.80

96.76

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

111.43

110.91

124.57

135.72

142.13

Provisions made

-

-

-

-

-

Depreciation

21.51

22.14

22.37

20.92

21.98

Taxation

-6.65

3.06

12.20

6.44

-0.88

Net profit / loss

32.04

13.35

16.13

14.94

15.31

Extra ordinary item

-

-

-

-0.02

-0.01

Prior year adjustments

-

-

-

-

-

Equity capital

92.16

92.16

92.16

92.16

91.96

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.92

13.48

12.22

13.45

10.33

GPM (%)

8.75

7.70

8.92

7.65

5.75

NPM (%)

5.97

2.67

2.84

2.70

2.42